Send Email Send Email
Kadcyla 160 mg Injection Kadcyla 160 mg Injection Kadcyla 160 mg Injection Kadcyla 160 mg Injection Kadcyla 160 mg Injection

Kadcyla 160 mg Injection

225000.0 INR
Get a Price/Quote

Product Details:

  • Origin of Medicine Switzerland
  • Physical Form Powder
  • Recommended For DOCTOR
  • Quantity 1 Pieces
  • Click to view more
Request To Call Back Send Inquiry
X

Kadcyla 160 mg Injection Price And Quantity

  • 1 Piece
  • 225000.0 INR
  • Intravenous
  • 160 mg
  • White to off-white
  • Anticancer injection
  • Vial

Kadcyla 160 mg Injection Product Specifications

  • DOCTOR
  • 1 Pieces
  • Powder
  • Switzerland
  • Intravenous
  • 160 mg
  • White to off-white
  • Anticancer injection
  • Vial

Kadcyla 160 mg Injection Trade Information

  • 1 Week

Product Description

Kadcyla 160 mg injection is a targeted therapy designed for individuals diagnosed with specific types of breast cancer, particularly those characterized by high levels of the HER2 protein. This innovative medication combines a monoclonal antibody with a microtubule inhibitor, effectively delivering treatment directly to cancer cells while minimizing damage to healthy tissues. By binding to the HER2 protein on cancer cells, Kadcyla disrupts their growth and proliferation, offering a strategic approach to combatting aggressive breast cancer. Patients should be aware of potential side effects, including fatigue, nausea, and infusion-related reactions, which necessitate close monitoring during treatment. Its essential to discuss any pre-existing health conditions and medications with your healthcare provider prior to starting Kadcyla to ensure safe administration. With its targeted action, Kadcyla is paving the way for more personalized cancer treatments, giving hope to those affected by HER2-positive breast cancer. Always consult with your oncologist to determine if Kadcyla is the right choice for your specific situation.

How Does Kadcyla 160 mg Injection Work?

Kadcyla 160 mg Injection is a targeted therapy that combines the HER2-targeted properties of trastuzumab with a chemotherapy agent (DM1). Once administered intravenously, the medication attaches to HER2-positive cancer cells and delivers chemotherapy directly into them, causing their destruction while limiting damage to healthy tissue.


When Should Kadcyla 160 mg Injection Be Administered?

Kadcyla is primarily used after prior treatment with trastuzumab and chemotherapy in individuals with HER2-positive breast cancer. The specific schedule is determined by a doctor, typically every three weeks, and is based on the patient's individual medical profile and response to therapy.


Benefits of Kadcyla 160 mg Injection

Kadcyla offers dual action against cancer by targeting cancer cells more specifically, which can result in improved treatment outcomes and potentially fewer side effects compared to standard chemotherapy. It is a trusted choice globally, with its Swiss origin providing an additional assurance of quality.

FAQ's of Kadcyla 160 mg Injection:


Q: How should Kadcyla 160 mg Injection be administered?

A: Kadcyla 160 mg Injection is administered by a medical professional through intravenous infusion. The powder is first reconstituted, then diluted, and infused directly into a patient's bloodstream under hospital or clinic supervision.

Q: What is the main use of Kadcyla 160 mg Injection?

A: Kadcyla 160 mg Injection is primarily used in the treatment of HER2-positive breast cancer, especially when other therapies like trastuzumab and chemotherapy alone have already been tried.

Q: When is the Kadcyla 160 mg Injection given during cancer treatment?

A: Kadcyla is typically administered after the patient has completed other HER2-targeted therapies and chemotherapy, as per the recommendation of the treating doctor.

Q: Where can healthcare providers obtain Kadcyla 160 mg Injection in India?

A: This injection is available through authorized distributors, exporters, suppliers, traders, and wholesalers throughout India, with distribution strictly limited to licensed medical institutions.

Q: What is the process for preparing and using Kadcyla 160 mg Injection?

A: A healthcare provider will reconstitute the white to off-white powder with sterile water before further diluting and administering it by intravenous infusion. Strict aseptic techniques and dosing protocols are always followed.

Q: What are the potential benefits of using Kadcyla 160 mg Injection over conventional chemotherapy?

A: Kadcyla targets and destroys cancer cells more specifically with reduced harm to healthy tissue, often resulting in improved outcomes and fewer adverse effects compared to conventional chemotherapy protocols.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category

Alkacel PGF 50 mg Injection
Send Inquiry
Adpaxil 100 mg Injection
Send Inquiry
Decitex 30 mg Injection
Send Inquiry
Celcarb 450 mg Injection
Send Inquiry
SEND INQUIRY CALL ME FREE


Contact Details
Address

    GST : 24ABNCS9569B1ZX

  • D-620, Swati Clover, Shilaj Cross Road, S. P. Ring Road, Shilaj,Ahmedabad - 380059, Gujarat, India
  • Phone : 08071930881
Key Personnel
  • Mr Siddharth Patel (MANAGING DIRECTOR)
  • Mobile : 08071930881
Quick Links
Our Products
View All
  • trusted seller
  • Send Inquiry Send Inquiry
    Send SMS Send SMS
       
    Call Me Call Me Free
    Back to top
    Tradeindia
    SIDMEX INOVIA PRIVATE LIMITED All Rights Reserved.(Terms of Use)
    Developed and Managed by Infocom Network Private Limited.
    Change Language